The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.

Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

Coronary Artery Disease

Percutaneous Transluminal Coronary Angioplasty

Consecutive patients receiving New DES without a mixture of other DES

Evaluation of Effectiveness and Safety of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

MD,PhD, Chairman,Heart Institute, Asan Medical Center,University of Ulsan,College of Medicine

consecutive patients receiving CYPHER stent

consecutive patients receiving Xience stent

consecutive patients receiving GENOUS stent

consecutive patients receiving PROMUS-ELEMENT stent

consecutive patients receiving XIENCE-PRIME stent

consecutive patients receiving NOBORI stent

consecutive patients receiving RESOLUTE-INTEGRITY stent

consecutive patients receiving XIENCE-XPEDITION stent

consecutive patients receiving BIOMATRIX stent

consecutive patients receiving CILOTAX stent

consecutive patients receiving Drug eluting balloon

consecutive patients receiving DESYNE stent

consecutive patients receiving PROMUS-PREMIER stent

consecutive patients receiving ORSIRO stent

consecutive patients receiving ONYX stent

consecutive patients receiving Bioresorbable Vascular Scaffold

consecutive acute myocardial infarction patients receiving Bioresorbable Vascular Scaffold

consecutive patients receiving Ultimaster stent

consecutive patients receiving Synergy stent

consecutive patients receiving Biofreedom stent

consecutive patients receiving Firehawk stent

consecutive patients receiving DESyne X2 stent

consecutive patients receiving Sierra stent

consecutive patients receiving Tansei stent

consecutive patients receiving Synergy XD or Synergy Megatron™ stent

consecutive patients receiving Xience-Skypoint stent

consecutive patients receiving Coroflex ISAR NEO stent

Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

About this trial

Study ID

Status

Type

Placebo

Accepting

Trial Timing

What is this trial about?

What are the participation requirements?